Abstract
Pyogenic liver abscesses are uncommon conditions that present diagnostic and therapeutic challenges to physicians. If left untreated, these lesions are invariably fatal. Liver abscesses have been recognized since the age of Hippocrates. In 1883, Koch described amebae as a cause of liver abscess. In 1938, Ochsner and DeBakey published the largest series of pyogenic and amebic liver abscesses in the literature. Since the late 20th century, percutaneous drainage has become a useful therapeutic option.
References
Barakate MS, Stephen MS, Waugh RC, Gallagher PJ, Solomon MJ, Storey DW, Sheldon DM. Pyogenic liver abscess a review of 10 years' experience in management. Aust N Z J Surg. 1999; 69:205–209.
Pang TC, Fung T, Samra J, Hugh TJ, Smith RC. Pyogenic liver abscesses. An audit of 10 years' experience. World J Gastroenterol. 2011; 17(12):1622–1630.
Wong WM, Wong BC, Hui CK, Ng M, Lai KC, Tso WK, Lam SK, Lai CL. Pyogenic liver abscess retrospective analysis of 80 cases over a 10-year period. J Gastroenterol Hepatol. 2002; 17:1001–1007.
Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin North Am. 2000; 14:547–563.
Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Kornprat P, Bernhardt GA, Mischinger HJ. Treatment of patients with pyogenic liver abscess. Chemotherapy. 2005; 51:366–369.
How to cite this article:
Batabyal B. An overview on Pyogenic Liver Abscess. Int. J. Res. Dev. Pharm. L. Sci. 2017; 6(6): 2793-2795. Doi: 10.13040/IJRDPL.2278-0238.6(6). 2793-2795.
This Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array